republic-os/legislation/us/states/ut/2022/hb-167.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	H.B. 167 Mental Illness Psychotherapy Drug Task Force	H.B. 167 Mental Illness Psychotherapy Drug Task Force	us/states/ut	Utah Legislature	2022	HB 167	Utah HB 167 (2022)	bill	Controlled Substances Department of Human Services Health Health Care Human Services Legislative Committees and Task Forces Mental Health	enacted	Brammer, Brady	2	36	6	2022-01-17	2022-03-22	openstates	ocd-bill/d689cf06-6ceb-4d5d-a6c7-9807781f951b	https://le.utah.gov/~2022/bills/static/HB0167.html	3069976b973e61cc21a8f89ef0a8e355a0526cccca65b01512e4549765345b38	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-ut

Utah HB 167 (2022) — H.B. 167 Mental Illness Psychotherapy Drug Task Force

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. Introduced (filed) — source
2. Enrolled (enrolled) — source

Votes

• Senate Comm - Favorable Recommendation — 5–1 (pass) · lower
• House Comm - Favorable Recommendation — 10–1 (pass) · lower
• House Comm - Substitute Recommendation from # 0 to # 1 — 11–0 (pass) · lower
• passed 3rd reading — 68–1 (pass) · lower
• passed 2nd reading — 24–1 (pass) · upper
• passed 3rd reading — 23–1 (pass) · upper

Sponsors

• Brammer, Brady — primary (person)
• Vickers, Evan J. — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2022-01-17 Bill Numbered but not Distributed
• 2022-01-17 Numbered Bill Publicly Distributed
• 2022-01-18 received bill from Legislative Research
• 2022-01-18 1st reading (Introduced) introduction, reading-1
• 2022-01-21 received fiscal note from Fiscal Analyst
• 2022-01-25 to House Health and Human Services Committee referral-committee
• 2022-02-02 House Comm - Substitute Recommendation from # 0 to # 1
• 2022-02-02 House Comm - Favorable Recommendation committee-passage-favorable
• 2022-02-03 comm rpt/substituted
• 2022-02-03 2nd reading reading-2
• 2022-02-04 fiscal note sent to sponsor
• 2022-02-07 fiscal note publicly available
• 2022-02-10 3rd reading reading-3
• 2022-02-10 passed 3rd reading passage
• 2022-02-10 to Senate
• 2022-02-11 received from House
• 2022-02-11 1st reading (Introduced) introduction, reading-1
• 2022-02-14 to Senate Health and Human Services Committee referral-committee
• 2022-02-16 Senate Comm - Not Considered
• 2022-02-22 Senate Comm - Favorable Recommendation committee-passage-favorable
• 2022-02-22 committee report favorable committee-passage-favorable
• 2022-02-22 placed on 2nd Reading Calendar
• 2022-02-24 2nd reading reading-2
• 2022-02-24 passed 2nd reading reading-2
• 2022-02-25 3rd reading reading-3
• 2022-02-25 passed 3rd reading passage
• 2022-02-25 signed by President/returned to House
• 2022-02-25 to House
• 2022-02-25 received from Senate
• 2022-02-25 signed by Speaker/sent for enrolling
• 2022-03-01 Bill Received from House for Enrolling
• 2022-03-01 Draft of Enrolled Bill Prepared
• 2022-03-10 Enrolled Bill Returned to House or Senate
• 2022-03-10 enrolled bill to Printing
• 2022-03-10 to Governor executive-receipt
• 2022-03-22 Governor Signed executive-signature

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/d689cf06-6ceb-4d5d-a6c7-9807781f951b. Confidence: reported (aggregated from official Utah legislature records).